Apollo Hospitals to leverage Microsoft’s AI, Machine Learning to record cardiovascular disease risk score

2018-08-21 09:29:56

Microsoft and Apollo Hospitals have jointly launched a first AI-powered Cardiovascular Disease Risk Score API, designed specifically to predict the risk of Cardiovascular Disease (CVD) in the Indian population.By Team ABLESoftware giant Microsoft and Apollo Hospitals have jointly launched a first AI-powered Cardiovascular Disease Risk Score API (Application Program Interface), designed specificall

Read more

NIH begins first-in-human trial of live, attenuated Zika Vaccine

2018-08-21 09:28:57

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases. By Team ABLENIAID has announced that the Institute will initiate a sponsored trial of Zika Vaccine. Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine deve

Read more

Novo Nordisk pays $800 million to gain full rights to Ziylo’s glucose binding molecules

2018-08-21 09:27:41

Ziylo is a supramolecular chemistry company that has developed a third \'biomimetic\' class of glucose binding molecules (GBMs).By Team ABLEZiylo and Novo Nordisk A/S have announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at Unit DX science incubator in Bristol, UK. Ziylo has been pioneering the use of its platform technology - synt

Read more

International team of scientists including 18 Indian scientists decode complex wheat genome

2018-08-21 09:26:11

This project was financially supported by the Department of Biotechnology, Government of India. The availability of this high quality reference genome would address global food security in the decades to come.By Team ABLEIn a major scientific breakthrough, a team of international researchers, including 18 from India decoded the wheat genome, considered insurmountable so far. The information genera

Read more

IIT-H Professor Aravind Kumar Rengan chosen for NASI-Young Scientist awards

2018-08-17 07:40:58

Aravind Kumar Rengan, Assistant Professor, Plasmonic NAnoSpace (P-NAS) Laboratory, Department of Biomedical Engineering, IIT Hyderabad, was chosen in the Bio-medical, Molecular Biology and Biotechnology category.By Team ABLE Two Indian Institute of Technology-Hyderabad (IIT-H), Professors have been chosen for the NASI-Young Scientist Platinum Jubilee Awards (2018) by the National Academy of S

Read more

Montana plant sciences faculty part of international discovery in wheat genome sequence

2018-08-17 07:39:08

It was revealed in the press release that sequencing the bread wheat genome was long considered an impossible task, due to its enormous size - five times larger than the human genome - and complexityBy Team ABLEA Montana State University (MSU) faculty member working on researching cereal genetics and genomics for Montana farmers is part of an international research team that published an article d

Read more

PAREXEL appoints two key executives to manage global business

2018-08-17 07:37:43

PAREXEL has appointed Greg Rush as Executive Vice President and Chief Financial Officer and Michele Fournier as Senior Vice President and Chief Human Resources Officer.By Team ABLEPAREXEL International Corporation, global innovator of biopharmaceutical services, has announced the appointment of Greg Rush as Executive Vice President and Chief Financial Officer and Michele Fournier as Senior Vice Pr

Read more

US FDA approves first generic version of EpiPen

2018-08-17 07:36:24

Teva Pharmaceuticals USA has gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.By Team ABLEThe U.S. Food and Drug Administration approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patien

Read more

Second edition of National Bio Entrepreneurship Competition launched; aims to identify path breaking life sciences’ ideas

2018-08-17 07:35:05

The National Bio Entrepreneurship Competition is organized by C-CAMP as part of the BIRAC Regional Entrepreneurship Centre (BREC) established at C-CAMP, Bengaluru.By Team ABLEThe National Bio Entrepreneurship Competition, a national platform to attract, identify, and nurture bio-entrepreneurs with path-breaking ideas for societal impact, was launched on 16th August, 2018 in New Delhi, by Prof. K.

Read more

Merck awarded Australian CRISPR Nickase Patent for foundational genome-editing technology

2018-08-16 08:42:17

The allowed patent application covers a foundational CRISPR strategy in which two CRISPR nickases are targeted to a common gene target. By Team ABLEScience and technology company,Merck has announced that the Australian Patent Office has allowed the company\'s patent application for the use of paired CRISPR nickases. Paired nickases represent a significant step in increasing safety by driving

Read more